| Literature DB >> 20233133 |
Xin-Ling Liang1, Shuang-Xin Liu, Yuan-Han Chen, Li-Jun Yan, Heng Li, Hui-Jie Xuan, Yong-Zheng Liang, Wei Shi.
Abstract
The aim of this nested case-control study was to assess the combined use of urinary kidney injury molecule (KIM)-1 and interleukin (IL)-18 for acute kidney injury (AKI) after cardiopulmonary bypass surgery (CPB). From a cohort of 122 subjects who underwent CPB, serial urinary KIM-1 and IL-18 concentrations were determined in 30 AKI and 92 non-AKI patients. An increased level of urinary KIM-1 was associated with the occurrence of AKI, whereas an increased level of IL-18 was related to progressive AKI. The combination of these two biomarkers facilitates the early diagnosis and assessment of the likely progression of AKI after CPB.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20233133 DOI: 10.3109/13547501003706558
Source DB: PubMed Journal: Biomarkers ISSN: 1354-750X Impact factor: 2.658